Training-induced right ventricular (RV) enlargement is frequent in athletes. Unfortunately, RV dilatation is also a common phenotypic expression and one of the diagnostic criteria of arrhythmogenic RV cardiomyopathy (ARVC). The current echocardiographic reference values derived from the general population can overestimate the presence of RV dilatation in athletes. We performed a meta-analysis of the literature to derive the proper reference values for assessing RV enlargement in competitive athletes. We conducted systematic review of English-language studies in the MEDLINE, Scopus, and Cochrane databases investigating RV size and function by echocardiography and by cardiac magnetic resonance (CMR) in competitive athletes. In total, 6,806 and 740 competitive athletes were included for the echocardiographic and CMR quantification of the RV, respectively. In this review, we present normal reference values for RV size and function to be applied in competitive athletes according to the disciplines practiced. The reference ranges reported in this review suggest that physicians should be aware that application of the current recommendations for normal population could be misleading when evaluating athletes. We suggest using these normative reference values, obtained in competitive athletes, to avoid the potential for mistakenly concluding, in this specific population, that RV size or function are abnormal.
Highlights
- •
The RV of competitive athletes is often enlarged when applying the current cutoffs.
- •
The current recommendations for the general population cannot be applied to athletes.
- •
In this study, normative reference values were obtained in competitive athletes.
- •
Athletes engaged in combined sports exhibit the greatest degree of RV remodeling.
- •
RV function can be slightly reduced at rest in healthy competitive athletes.
Right ventricular (RV) enlargement is a common phenotypic expression and one of the established criteria for the diagnosis of arrhythmogenic RV cardiomyopathy (ARVC) ; however, this finding is not uncommonly reported in other conditions, including the “athlete’s heart.” Specifically, RV enlargement has been described as a morphologic hallmark in imaging studies of a large proportion of the athletic population, with the extent of remodeling being more marked in individuals engaged in the endurance disciplines. In these instances, the training-induced dimensional increase of the RV may even overlap with the pathological dilatation of the RV in patients with ARVC, raising the question of a challenging differential diagnosis.
The judgment of whether the RV enlargement is consistent with a physiologic adaptation has enormous importance, and, despite several reports having previously described the morphologic characteristics of the RV in athletes, a definitive assessment of the reference values for standard echocardiographic measurements of the right heart in competitive athletes is still lacking.
Reference values were previously published by the American Society of Echocardiography and the European Association of Echocardiography, and revised recommendations have been further released. Unfortunately, these documents have not included athletes and do not take into account the exercise-induced RV remodeling. Therefore, quantification of RV dimensions in athletes’ cohorts based on these reference values may be misleading and a possible source of misdiagnosis, with potential unwarranted clinical consequences.
Therefore, we believed it to be timely and appropriate to conduct a meta-analysis from all available studies referring to athletes, in order to derive the normative reference values for RV dimensions and function by echocardiography and cardiac magnetic resonance (CMR) to be implemented in the clinical evaluation of competitive athletes.
Methods
Data Source and Searches
We conducted a systematic literature search of the MEDLINE, Scopus, and Cochrane databases from inception to April 30, 2016. We also included articles published online ahead of print at the time of our search. The primary search used the following keywords: echo or cardiac magnetic resonance (CMR) or CMR imaging, with or without: Doppler, colour, stress, three-dimensional; right heart; right ventricular: dimension, function, size, structure. In addition, the population search used the following items: athletes, training, exercise. Where applicable, keywords were searched as the root and truncation symbol (e.g., ventric*). Additionally, we manually searched references from papers about studies, review articles, and meta-analyses. All searches were confined to human studies. Studies not in English were excluded.
Study Selection
We assessed studies for inclusion by using the following a priori defined criteria: (1) the study explicitly stated that it evaluated competitive athletes, with no history of cardiovascular disease; (2) the study reported at least three parameters of RV dimensions and function, measured by CMR or two-dimensional echocardiography according to current clinical standards ; (3) the mean age of the study cohort was set between 18 and 39 years both for echocardiographic and CMR studies; (4) a measure of statistical variance was reported; (5) year of publication ≧1990 for echocardiographic studies and ≧2000 for CMR studies. Because of the paucity of CMR data referring to female athletes, for CMR studies only male athletes were analyzed. Study arms that reported populations that potentially overlapped with other studies were excluded. Echocardiographic studies with ≤20 athletes were also excluded.
A flowchart showing the derivation of the reference cohort is shown in Figure 1 for echocardiographic studies and in Figure 2 for CMR studies.
Data Collection
Each eligible article meeting the inclusion criteria was reviewed by two independent reviewers (M.S. and F.L.) who compared decision-making and discussed disagreements. Discrepancies were resolved by consensus. Each data set was reviewed for units and methods of measurement, range checks were performed to identify and exclude biologically implausible values, and summary statistics were cross-checked against published results, where available. Athletes were classified into strength (such as bodybuilders and weightlifters), endurance (such as long-distance runners, swimmers, and cross-country skiers), and combined (such as rowers, cyclists, and speed skaters) groups according to the intensity level of static and dynamic components. Heterogeneous groups of athletes of different sports classifications were categorized as mixed.
In longitudinal studies investigating training-induced RV remodeling, the RV measurements after the longest exercise exposure were used.
Data Synthesis, Statistical Analysis, and Development of Reference Values
To explore the influence of type of training (endurance, strength, mixed, or combined disciplines), gender, and age on right heart size and function, a meta-analysis was conducted to integrate the results of a set of studies about RV parameters measured by echocardiography and CMR in competitive athletes engaged in different disciplines. Specifically, a meta-regression was used that allowed for between-study heterogeneity. The class of sports activity (i.e., endurance vs nonendurance disciplines) and age were included in the model as moderator variables. Since the levels of the moderators may influence the heterogeneity among the studies, the meta-regression analysis was based on a mixed effects model. Mixed effects models provided unconditional inference about the average effect in the entire population of studies from which the included studies were assumed to be randomly selected. The Knapp-Hartung adjustment to the standard errors of the estimated coefficients was applied in order to adjust the statistics and the confidence intervals of the estimates so that their significance properties are closer to the nominal 5% type I error and the confidence intervals maintain a 95% coverage level. Therefore, the tests on individual coefficients as well as the confidence intervals relied on t distributions with k – 1 degrees of freedom, where k is the number of studies. An underlying heteroskedastic covariance structure was considered in the study-aggregate meta-analysis. The sampling variances were calculated based on large sample approximation. Maximum-likelihood estimation was used when estimating the heterogeneity parameters of meta-analysis. The between-study heterogeneity in the true measurements of the dependent variables was assessed by the parameter τ 2 , and its percentage over the total variability in the effect size estimates was also calculated ( I 2 ). A test of the residual heterogeneity ( Q statistic) was also applied. For each variable, a sequence of two meta-regressions were implemented, which included the reduced model consisting of the basic random effects model (i.e., a meta-regression without moderators) and the models with the Class moderator. The Bayesian information criterion (BIC) was used for model selection among the above finite set of models. The model with the lowest BIC was preferred. The coefficients from the selected model quantified the direction and magnitude of the relationship between the average “true” outcome in the population of studies and the moderator variable(s) included in the model. The 95% CIs around the estimated average outcome and prediction intervals of new possible data were provided for different levels of the significant moderators. We also reported 99% CIs in order to provide further information. Forest plots gave the graphical overview of the results from the fitted model. Funnel plots were also drawn, and the Egger’s regression test for funnel plot asymmetry indicated whether either publication bias or systematic difference between larger and smaller studies occurred. Significant rejection of the null hypothesis of symmetry therefore would cast doubts on the reliability of the metaregression.
The coefficients from the fitted model estimated the direction and magnitude of the relationship between the average true outcome in the population of studies and the moderator variable included in the model.
RV reference values were defined at the 95 th percentile and lower reference values at the 5 th percentile. In accordance with earlier recommendations, these values defined 90% of the population as normal, but they allowed for nonnormal distributions.
Reference values were derived in male competitive athletes divided according to sports disciplines for RV size (RV outflow tract [RVOT] parasternal long-axis view [PLAX], RVOT parasternal short-axis view [PSAX], RV end-diastolic and end-systolic area, RV basal and midcavity diameter, RA area and their indexed values, and RV wall thickness) and RV function (fractional area change [FAC], tricuspid annular plane systolic excursion [TAPSE], s’ and e’ velocities, and RV strain). Reference values were established in male competitive athletes divided according to sports disciplines also by CMR for RV end-diastolic and end-systolic volumes, RV stroke volume, and RV ejection fraction. In female competitive athletes only the reduced meta-regression model was considered (i.e., reporting only mean values ± SE). All statistical analysis was carried out with the comprehensive software meta-analysis package for R: metafor 1.9-8 (2015-09-28).
Results
Our search of the literature for echocardiographic studies identified 361 articles for review ( Figure 1 ). Of these, 315 were excluded for various reasons, most commonly because the RV was not evaluated. Thus, 46 studies met the inclusion criteria for the analysis, and a final population of 6,806 athletes were included in the present meta-analysis. We also identified 84 articles for review of CMR studies ( Figure 2 ). Of these, 66 were excluded for various reasons. Thus, 18 studies met the inclusion criteria for the analysis, and a final population of 740 athletes were included in the present meta-analysis. Table 1 reports the demographic characteristics of the subjects of the articles included in this study.
First author, year | Type of sport | n | Gender | Ethnicity | Age, years | Height, cm | BSA, m 2 | Training regimen |
---|---|---|---|---|---|---|---|---|
Echocardiographic studies | ||||||||
Douglas, 1990 | Combined | 41 | M, F | nr | 38 ± 10 | nr | nr | nr |
Henriksen, 1996 | Endurance | 127 | M | nr | 22 ± 1 | 182 ± 1 | 1.90 ± 0.02 | nr |
Henriksen, 1999 | Endurance | 42 | F | Caucasian | 20 ± 1 | 169 ± 2 | 1.65 ± 0.03 | 300-600 hours/year |
Erol, 2002 | Mixed | 36 | M | nr | 22 ± 4 | nr | nr | 11.5 ± 3.9 hours/week |
D’Andrea, 2003 | Endurance | 32 | M | nr | 24 ± 2 | nr | 1.89 ± 0.5 | 15-20 hours/week |
Endurance | 26 | M | nr | 22 ± 3 | nr | 1.96 ± 0.6 | 15-20 hours/week | |
Kasikcioglu, 2005 | Mixed | 52 | M | Caucasian | 23 ± 4 | 173 ± 7 | 1.79 ± 0.13 | >10 hours/week |
Neilan, 2006 | Endurance | 20 | M, F | nr | 34 ± 10 | nr | nr | 42 ± 9 miles/wk |
Koç, 2007 | Mixed | 60 | M, F | nr | 21 ± 3 | nr | 2.0 ± 0.2 | 15 ± 5 hours/week |
Baggish, 2008 | Combined | 20 | F | nr | 19.6 ± 1 | 172 ± 8 | 1.8 ± 0.2 | 11.3 ± 2.4 hours/week |
Combined | 20 | M | nr | 19.2 ± 1.2 | 187 ± 6 | 2.1 ± 0.1 | 11.9 ± 2.2 hours/week | |
Combined | 24 | M | nr | 19.1 ± 0.5 | 187 ± 7 | 2.2 ± 0.2 | 13.3 ± 3.2 hours/week | |
La Gerche, 2008 | Combined | 27 | M, F | nr | nr | 179 ± 8 | nr | 19.2 ± 3.3 hours/week |
Poh, 2008 | Combined | 24 | M, F | American, Caucasian and Chinese | 22 ± 3 | nr | 1.6 ± 0.2 | nr |
Teske, 2009 | Mixed | 58 | M, F | nr | 28 ± 5 | 180 ± 7 | 1.9 ± 0.15 | 9-18 hours/week |
Mixed | 63 | M, F | nr | 27 ± 5 | 183 ± 8 | 1.96 ± 0.17 | >18 hours/week | |
Mixed | 54 | M, F | nr | 51 ± 7 | 176 ± 8 | 1.87 ± 0.18 | ≥ 9 hours/week | |
Baggish, 2010 | Combined | 20 | M | Caucasian | 25 ± 3 | 197 ± 5 | 2.3 ± 0.1 | 22 ± 6 hours/week |
Combined | 20 | M | Caucasian | 20 ± 2 | 186 ± 6 | 2.1 ± 0.2 | 11 ± 4 hours/week | |
Bauce, 2010 | Endurance | 40 | M, F | Caucasian | 26 ± 5 | 173 ± 20 | 1.84 ± 0.2 | 7 ± 1.7 hours/week |
D’Andrea, 2010 | Endurance | 50 | M | nr | 36 ± 8 | nr | 1.89 ± 0.11 | 15-20 hours/week |
D’Andrea, 2011 | Endurance | 370 | M, F | nr | 29 ± 10 | nr | 1.84 ± 0.5 | 15-20 hours/week |
Strength | 245 | M, F | nr | 29 ± 10 | nr | 1.89 ± 0.6 | 15-20 hours/week | |
Krol, 2011 | Combined | 38 | M, F | Caucasian | 25 ± 3 | 186 ± 10 | 2.1 ± 0.2 | nr |
La Gerche, 2011 | Endurance | 39 | M, F | nr | 36 ± 8 | 178 ± 6 | nr | 16.3 ± 5.1 hours/week |
Popovic, 2011 | Combined | 21 | M | nr | 21 ± 3 | nr | 2.12 ± 0.09 | 15 hours/week |
Strength | 16 | M | nr | 23 ± 3 | nr | 2.13 ± 0.27 | 17 hours/week | |
D’Andrea, 2012 | Endurance | 220 | M, F | nr | 28 ± 11 | nr | 1.83 ± 0.5 | 15-20 hours/week |
Strength | 210 | M, F | nr | 28 ± 9 | nr | 1.89 ± 0.7 | 15-20 hours/week | |
Karlstedt, 2012 | Endurance | 25 | M, F | nr | nr | 169 ± 8 | nr | 47 ± 7 miles/week |
Oxborough, 2012 | Mixed | 102 | M, F | nr | 36 ± 11 | 178 ± 8 | 2.02 ± 0.24 | 8-24 hours/week |
Bernheim, 2013 | Combined | 38 | M, F | nr | 38 ± 9 | nr | 1.9 ± 0.2 | 13.5 ± 3.5 hours/week |
D’Ascenzi, 2013 | Endurance | 100 | M, F | nr | 26 ± 5 | nr | 2.05 ± 0.23 | >15 hours/week |
King, 2013 | Combined | 18 | M | nr | 22 ± 4 | nr | 2.1 ± 0.1 | 3-8 low + 2-5 high + more super-high hours/week |
Endurance | 24 | M | nr | 24 ± 4 | nr | 2.0 ± 0.2 | 6-10.5 hours/week | |
Moro, 2013 | Endurance | 17 | M | nr | 33 ± 8 (overall) | 174 ± 1 | 1.81 ± 0.03 | 24 hours/week |
Endurance | 19 | M | nr | 173 ± 1 | 1.78 ± 0.02 | 12-18 hours/week | ||
Endurance | 21 | M | nr | 177 ± 1 | 1.92 ± 0.02 | 26 hours/week | ||
Pagourelias, 2013 | Mixed | 80 | M | Caucasian | 31 ± 10 | nr | 1.98 ± 0.15 | 14.6 ± 5.4 hours/week |
Strength | 28 | M | Caucasian | 27 ± 6 | nr | 1.95 ± 0.21 | 17.1 ± 7.2 hours/week | |
Schmied, 2013 | Endurance | 210 | M | African | 19 ± nr | 172 ± 6 | 1.70 ± 0.13 | nr |
Simsek, 2013 | Endurance | 44 | M, F | nr | 24 ± 3 | nr | nr | 14-18 hours/week |
Vitarelli, 2013 | Endurance | 35 | M | nr | 28.7 ± 10.7 | nr | 1.91 ± 0.15 | >15 hours/week |
Strength | 35 | M | nr | 30.3 ± 9.4 | 1.98 ± 0.18 | >15 hours/week | ||
Strength | 35 | M | nr | 29.4 ± 9.8 | 1.93 ± 0.13 | > 15 hours/week | ||
Zaidi, 2013 | Mixed | 300 | M, F | Black (black African, black Afro-Caribbean, black British) | 22 ± 5 | nr | 1.97 ± 0.2 | 16.5 ± 6.1 hours/week |
Mixed | 375 | M, F | white | 22 ± 5 | nr | 1.94 ± 0.2 | 20.3 ± 7.0 hours/week | |
Zaidi, 2013 | Mixed | 627 | M, F | ND | 22 ± 5 | nr | nr | 19.8 ± 7.5 |
D’Ascenzi, 2014 | Endurance | 24 | F | nr | 25 ± 4 | nr | 1.87 ± 0.11 | 16 hours/week |
Esposito, 2014 | Combined | 40 | M | Caucasian | 28 ± 10 | nr | nr | >30 hours/week for 4 years |
Gjerdalen, 2014 | Endurance | 553 | M | 504 Caucasian, 49 African | 25 ± 5 | 183 ± 6 | 2.0 ± 0.1 | nr |
Leischik, 2014 | Combined | 54 | M | nr | 38 ± 12 | 182 ± 7 | 1.97 ± 0.14 | nr |
Combined | 33 | F | nr | 34 ± 8 | 169 ± 6 | 1.70 ± 0.13 | ||
Giraldeau, 2015 | Mixed | 45 | M | Caucasian | 19 ± 1 | 182 ± 7 | 2.06 ± 0.17 | nr |
Mixed | 45 | F | Caucasian | 19 ± 1 | 168 ± 6 | 1.71 ± 0.12 | ||
Grunig, 2015 | Endurance | 395 | M, F | nr | nr | nr | nr | 15-20 hours/week |
Strength | 255 | M, F | nr | nr | ||||
Hedman, 2015 | Mixed | 46 | F | nr | 21 ± 2 | 1.68 ± 0.06 | 1.69 ± 0.1 | 13 ± 5 hours/week |
Jongman, 2015 | Combined | 24 | M | nr | 28 ± 5 | nr | 1.9 ± 0.1 | 24.3 ± 5.6 hours/week |
Major, 2015 | Mixed | 52 | M | Caucasian | 25 ± 5 | nr | 1.95 ± 0.14 | 18.9 ± 6.7 hours/week |
Malmgren, 2015 | Endurance | 33 | F | nr | 20 ± 2 | 175 ± 7 | 1.90 ± 0.1 | 10.8 ± 2.3 hours/week |
Utomi, 2015 | Endurance | 19 | M | Caucasian | 34 ± 5 | 180 ± 10 | 2.1 ± 0.2 | 12 hours/week |
Strength | 21 | M | Caucasian | 29 ± 8 | 180 ± 10 | 2.3 ± 0.3 | 11 hours/week | |
D’Ascenzi, 2016 | Endurance | 35 | M, F | nr | 22 ± 7 | nr | 2.1 ± 0.2 | >20 hours/week for 4 weeks, then 12 hours/week + 1 or 2 matches/week |
D’Ascenzi, 2016 | Endurance | 29 | M, F | nr | 21 ± 7 | nr | 2.2 ± 0.2 | nr |
D’Ascenzi, 2017 | Mixed | 262 | M, F | Caucasian | 24 ± 6 (overall) | nr | 1.9 ± 0.2 | nr (Olympic athletes) |
Strength | 277 | nr | 1.8 ± 0.2 | |||||
Mixed | 216 | nr | 1.9 ± 0.2 | |||||
Mixed | 254 | nr | 2.0 ± 0.2 | |||||
CMR studies | ||||||||
Petersen, 2006 | Mixed | 20 | M | nr | 25 ± 4 | 185 ± 10 | 2.01 ± 0.2 | 22 ± 7 |
Perseghin, 2007 | Endurance | 9 | M | nr | 26 ± 5 | nr | 2.11 ± 1.2 | nr |
Combined | 14 | M | 23 ± 3 | nr | 1.92 ± 0.1 | nr | ||
Esch, 2010 | Combined | 8 | M | nr | 31 ± 9.7 | 179.1 ± 11.2 | nr | 11.5 ± 3.1 |
Prakken, 2010 | Mixed | 83 | M | nr | 26 ± 6.4 | 186 ± 7.3 | 2 ± 0.2 | 12 ± 2.4 |
Mixed | 46 | M | nr | 26 ± 4.9 | 186 ± 7.3 | 2 ± 0.2 | 24 ± 5.6 | |
Scharf, 2010 | Endurance | 29 | M | White | 24.6 ± 3.9 | 184 ± 4.4 | 2.03 ± 0.8 | nr |
Scharf, 2010 | Combined | 26 | M | nr | 27.9 ± 3.5 | 184 ± 5 | 1.99 ± 0.1 | nr |
Steding, 2010 | Endurance | 11 | M | nr | 25 ± 6 | 186 ± 0.05 | 2.1 ± 0.08 | nr |
Endurance | 18 | M | nr | 24 ± 5 | 183 ± 0.05 | 2.01 ± 0.08 | nr | |
Combined | 12 | M | nr | 35 ± 9 | 184 ± 0.05 | 2.03 ± 0.1 | >10 hours/week | |
Luijkx, 2012 | Endurance | 28 | M | European | 23 ± 4.6 | 183 ± 5.9 | 2 ± 0.13 | 16 ± 4.4 |
Endurance | 10 | M | African | 23 ± 2.8 | 179 ± 4.8 | 1.95 ± 0.1 | 14 ± 2.8 | |
Luijkx, 2012 | Endurance | 93 | M | nr | 24 ± 4.3 | 183 ± 6.4 | 1.97 ± 0.15 | 16 ± 6.1 |
Combined | 57 | M | nr | 27 ± 5 | 186 ± 7.3 | 2.02 ± 0.16 | 23 ± 5.9 | |
Strength | 27 | M | nr | 26 ± 5.8 | 181 ± 8.2 | 2.13 ± 0.23 | 13 ± 5.1 | |
Erz, 2013 | Mixed | 18 | M | nr | 37 ± 7.6 | 182 ± 4 | 1.9 ± 0.14 | 13.7 ± 5.8 |
Franzen, 2013 | Combined | 20 | M | nr | 38.7 ± 6.2 | 181 ± 10 | 1.93 ± 0.1 | 17.1 ± 4.5 |
Luijkx, 2013 | Strength | 28 | M | nr | 27 ± 6.5 | 180 ± 7.4 | 2.13 ± 0.21 | 11.5 hours/week |
Combined | 52 | M | nr | 28 ± 5.6 | 185 ± 7.0 | 2 ± 0.15 | ||
Mangold, 2013 | Mixed | 73 | M | nr | 37.4 ± 11.4 | 181 ± 6.1 | 1.91 ± 0.13 | 13.1 ± 4.5 |
Steding-Ehrenborg, 2013 | Endurance | 16 | M | nr | 25 ± 5 | 183 ± 0.05 | 2.03 ± 0.10 | nr |
Claessen, 2014 | Combined | 14 | M | nr | 36 ± 6 | nr | nr | 13 ± 5 hours/week |
La Gerche, 2015 | Combined | 10 | M | nr | 35 ± 6 | nr | nr | 11 (6-15) hours/week |
Dupont, 2017 | Combined | 12 | M | nr | 32.3 ± 7.1 | 181 ± 0.07 | 1.93 ± 0.11 | >8 hours/week |
Steding-Ehrenborg, 2016 | Endurance | 6 | M | nr | 23 ± 3 | 183 ± 8 | 1.92 ± 0.16 | nr |
The mean body surface area (BSA) of the overall population was 2.0 ± 0.2 m 2 , while the mean resting heart rate was 56.2 ± 0.7 bpm and systolic and diastolic blood pressure were 123 ± 2 and 75 ± 1 mmHg, respectively. The number of studies and subjects available for each echocardiographic and CMR parameter and the results of heterogeneity tests in the final analysis are shown in Table 2 .
Studies ( n ) | Subjects ( n ) | I 2 | Q | P value Q | |
---|---|---|---|---|---|
Male athletes | |||||
RV echocardiographic parameters | |||||
RVOT PLAX | 8 | 355 | 58.9 | 22.0 | .0002 |
RVOT PLAX index | 4 | 191 | 0 | 2.2 | .14 |
RVOT PSAX | 6 | 299 | 0 | 0.19 | .91 |
RVOT PSAX index | 4 | 191 | 0 | 2.0 | .16 |
RVOT distal diameter | 4 | 217 | 0 | 0.90 | .64 |
RVOT distal diameter index | 3 | 167 | 0 | 0.74 | .39 |
RV end-diastolic area | 16 | 1221 | 0 | 8.2 | .76 |
RV end-diastolic area index | 9 | 746 | 0 | 4.5 | .48 |
RV end-systolic area | 12 | 890 | 0 | 5.0 | .76 |
RV end-systolic area index | 5 | 637 | 0 | 0.75 | .68 |
RV basal diameter | 12 | 1031 | 0 | 7.5 | .49 |
RV basal diameter index | 7 | 788 | 0 | 9.9 | .04 |
RV midcavity diameter | 18 | 1210 | 0 | 13.4 | .50 |
RV midcavity diameter index | 5 | 744 | 49.2 | 9.0 | .01 |
RA area | 5 | 895 | 0 | 1.2 | .27 |
RV wall thickness | 8 | 852 | 0 | 1.6 | .90 |
FAC | 15 | 732 | 0 | 12.8 | .31 |
TAPSE | 8 | 245 | 0 | 2.8 | .59 |
s’ | 14 | 451 | 0 | 10.8 | .37 |
e’ | 15 | 482 | 0 | 8.2 | .69 |
e’/a’ ratio | 11 | 434 | 58.8 | 19.9 | .006 |
RV strain | 12 | 430 | 0 | 2.7 | .95 |
RV parameters derived by CMR | |||||
End-diastolic volume | 18 | 398 | 40.6 | 28.6 | .02 |
End-systolic volume | 12 | 302 | 6.3 | 10.6 | .30 |
Stroke volume | 9 | 128 | 32.2 | 12.8 | .04 |
Ejection fraction | 23 | 704 | 33.6 | 32.7 | .03 |
Demographic characteristics | |||||
BSA | 28 | 1679 | 20.2 | 27.0 | .31 |
Resting heart rate | 26 | 1367 | 0 | 11.6 | .96 |
Height | 29 | 1720 | 95.0 | 843.6 | <.0001 |
Female athletes | |||||
RVOT PLAX | 6 | 285 | 0.34 | 6.71 | .15 |
RVOT PLAX index | 5 | 252 | 0 | 3.15 | .37 |
RVOT PSAX | 4 | 206 | 0 | 1.42 | .49 |
RVOT PSAX index | 4 | 206 | 0 | 0.55 | .76 |
RV end-diastolic area | 7 | 465 | 0 | 0.31 | .99 |
RV end-systolic area | 2 | 49 | 0 | 0.1 | .75 |
RV basal diameter | 7 | 312 | 0 | 0.68 | .98 |
RV midcavity diameter | 6 | 266 | 0 | 2.01 | .73 |
RA area | 6 | 258 | 0 | 1.66 | .8 |
RV FAC | 3 | 111 | 0 | 0.69 | .41 |
s’ velocity | 4 | 123 | 56.8 | 8.7 | .03 |
e’ velocity | 4 | 74 | 4.4 | 4.4 | .21 |
The reference values of RV size by echocardiography in male competitive athletes were reported in Table 3 . While RVOT diameters did not differ among the four groups, RV end-diastolic and end-systolic areas were significantly different among the four groups, reaching the greatest value in combined athletes and the lowest in strength-trained athletes. The same findings were observed also for RV end-diastolic and midcavity diameters, while RA area did not differ among the groups. While RV wall thickness was similar between endurance and mixed athletes, athletes engaged in combined disciplines showed the greater value. The reference values of RV function estimated by echocardiography are reported in Table 4 . The FAC was lower in athletes practicing endurance and combined disciplines, but the lower limit of normalcy was the same for all the groups (i.e., 32%), with the exception of the mixed group. Neither TAPSE nor E/A ratio differed among the groups, while s’ velocity and e’ velocity reached the highest value in endurance and strength athletes.
Mean (95% CI) | P value for class of sport | |
---|---|---|
RVOT PLAX (mm) | .69 | |
Endurance | 29 (26-33) | |
Combined | 29 (26-33) | |
Mixed | 29 (26-33) | |
Strength | 29 (26-33) | |
RVOT PLAX index (mm/m 2 ) | .79 | |
Endurance | 17 (15-18) | |
Combined | 17 (15-18) | |
Mixed | 17 (15-18) | |
Strength | 17 (15-18) | |
RVOT PSAX (mm) | .17 | |
Endurance | 34 (32-35) | |
Combined | 34 (32-35) | |
Mixed | 34 (32-35) | |
Strength | 34 (32-35) | |
RVOT PSAX index (mm/m 2 ) | .74 | |
Endurance | 18 (16-20) | |
Combined | 18 (16-20) | |
Mixed | 18 (16-20) | |
Strength | 18 (16-20) | |
RVOT distal diameter (mm) | .10 | |
Endurance | 31 (27-34) | |
Combined | 31 (27-34) | |
Mixed | 31 (27-34) | |
Strength | 31 (27-34) | |
RVOT distal diameter index (mm/m 2 ) | .80 | |
Endurance | 16 (15-18) | |
Combined | 16 (15-18) | |
Mixed | 16 (15-18) | |
Strength | 16 (15-18) | |
RV end-diastolic area (cm 2 ) | ||
Endurance | 23 (20-27) | Reference |
Combined | 32 (29-35) | .002 |
Mixed | 30 (28-31) | .005 |
Strength | 21 (17-25) | .33 |
RV end-diastolic area index (cm 2 /m 2 ) | .95 | |
Endurance | 15 (14-16) | |
Combined | 15 (14-16) | |
Mixed | 15 (14-16) | |
Strength | 15 (14-16) | |
RV end-systolic area (cm 2 ) | ||
Endurance | 13 (10-15) | Reference |
Combined | 17 (14-20) | .02 |
Mixed | 13 (8-18) | .79 |
Strength | 10 (8-13) | .18 |
RV end-systolic area index (cm 2 /m 2 ) | .67 | |
Endurance | 9 (7-10) | |
Combined | 9 (7-10) | |
Mixed | 9 (7-10) | |
Strength | 9 (7-10) | |
RV basal diameter (mm) | ||
Endurance | 40 (38-42) | Reference |
Combined | 44 (39-49) | .14 |
Mixed | 43 (41-44) | .02 |
Strength | 38 (31-45) | .59 |
RV basal diameter index (mm/m 2 ) | .46 | |
Endurance | 23 (19-26) | |
Combined | 23 (19-26) | |
Mixed | 23 (19-26) | |
Strength | 23 (19-26) | |
RV midcavity diameter (mm) | ||
Endurance | 29 (27-30) | Reference |
Combined | 41 (37-46) | <.0001 |
Mixed | 36 (35-37) | <.0001 |
Strength | 26 (23-29) | .07 |
RV midcavity diameter index (mm/m 2 ) | .69 | |
Endurance | 18 (14-22) | |
Combined | 18 (14-22) | |
Mixed | 18 (14-22) | |
Strength | 18 (14-22) | |
RA area (cm 2 ) | .60 | |
Endurance | 18 (14-23) | |
Combined | 18 (14-23) | |
Mixed | 18 (14-23) | |
Strength | 18 (14-23) | |
RV wall thickness (mm) | ||
Endurance | 4.2 (3.9-4.4) | Reference |
Combined | 7.0 (5-8) | .01 |
Mixed | nd | nd |
Strength | 4.0 (3-5) | .60 |
BSA (m 2 ) | ||
Endurance | 1.89 (1.80-1.97) | Reference |
Combined | 2.01 (1.99-2.20) | <.0001 |
Mixed | 1.93 (1.77-2.08) | .57 |
Strength | 2.00 (1.82-2.17) | .20 |
Heart rate (bpm) | ||
Endurance | 55 (53-57) | Reference |
Combined | 59 (56-64) | .04 |
Mixed | 52 (43-60) | .42 |
Strength | 60 (54-66) | .10 |
Height (cm) | .11 | |
Endurance | 182 (180-185) | |
Combined | 182 (180-185) | |
Mixed | 182 (180-185) | |
Strength | 182 (180-185) |